e-learning
resources
Vienna 2009
Wednesday, 16.09.2009
Translational models of lung disease
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Effects on cytokine expression in human plasmacytoid dendritic cells by prostaglandin I2 analogs
C. H. Hung (Kaohsiung, Taiwan)
Source:
Annual Congress 2009 - Translational models of lung disease
Session:
Translational models of lung disease
Session type:
Oral Presentation
Number:
4430
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
C. H. Hung (Kaohsiung, Taiwan). Effects on cytokine expression in human plasmacytoid dendritic cells by prostaglandin I2 analogs. Eur Respir J 2009; 34: Suppl. 53, 4430
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion: Diagnostic tools for Obstructive Sleep Apnoea in adults and children
Expert interview: Physiological classification of lung function impairment
Occupational exposures to respiratory diseases: A case-based discussion
Related content which might interest you:
Regulation of cytokine expression in human plasmacytoid dendritic cells by prostaglandin I2 analogues
Source: Eur Respir J 2009; 33: 405-410
Year: 2009
Effects of long-acting β2 agonist on cytokine expression in human plasmacytoid dendritic cells
Source: Annual Congress 2010 - Airway cells as targets for anti-inflammatory drugs
Year: 2010
5-Hydroxytryptamine modulates migration, cytokine and chemokine release and T-cell priming capacity of human dendritic cells
Source: Annual Congress 2009 - Airway cell biology
Year: 2009
NF-κB-dependent cytokine production is abolished by cyclopentenone prostaglandins in lung epithelial cells
Source: Eur Respir J 2001; 18: Suppl. 33, 354s
Year: 2001
Effects of dendritic cells overexpressing Serrate1 on the polarization of CD4+CD25+ T cells and the production of inhibitory cytokines
in vitro
Source: Eur Respir J 2005; 26: Suppl. 49, 25s
Year: 2005
Generation and activation of myeloid derived suppressor cells using prostaglandin E2 and EP receptor agonists in vitro
Source: International Congress 2019 – Advances in asthma pharmacology
Year: 2019
Activation of E-prostanoid4 and E-prostanoid2 receptors inhibits TNF-α release from human alveolar macrophages
Source: Eur Respir J 2007; 29: 986-994
Year: 2007
Increased COX-1 and COX-2 mRNA expression and prostaglandin E2 production by dendritic cells from patients with asthma
Source: Annual Congress 2003 - Intracellular signalling and regulation of cytokine production
Year: 2003
Differing effects of montelukast and ketotifen on cytokine expression in human myeloid dendritic cells
Source: Annual Congress 2010 - Regulation of airway pharmacology
Year: 2010
Effects of JAK-STAT inhibitors on glucocorticosteroid resistant release of CXCR3 chemokines from human bronchial epithelial cells
Source: Annual Congress 2011 - Epithelial cell biology
Year: 2011
Effect of TGFb on cytokine and costimulatory molecule expression by monocyte derived dendritic cells
Source: Annual Congress 2003 - Intracellular signalling and regulation of cytokine production
Year: 2003
Effects of long-acting beta2 agonists on Th1 and Th2 chemokines in monocytes and bronchial epithelial cells
Source: Annual Congress 2008 - Novel therapeutic approaches and immunological mechanisms in airway cell pathobiology
Year: 2008
The pro-apoptotic effect of cysteinyl leukotriene receptor (CysLT-R) antagonist montelukast is mediated by CysLT-Rs expression on antigen-stimulated T cells
Source: Eur Respir J 2003; 22: Suppl. 45, 100s
Year: 2003
Fevipiprant antagonises prostaglandin D2-induced activation of type-2 CD8 T cells (Tc2)
Source: International Congress 2019 – Novel targets and mechanisms in asthma
Year: 2019
Rolipram inhibits eotaxin-3 releasing in human epithelial cells BEAS-2B stimulated with Th2 cytokines
Source: Eur Respir J 2007; 30: Suppl. 51, 219s
Year: 2007
Organic dust induces intracellular production of cytokines in monocytes, NK and T cells
in vitro
Source: Eur Respir J 2001; 18: Suppl. 33, 113s
Year: 2001
Fevipiprant is superior to montelukast in suppressing type 2 cytokine production from mast cell stimulated human Th2 cells
Source: International Congress 2019 – Precision meets immunology in treatment of airway diseases
Year: 2019
Prostaglandin E2 suppresses the function of human group 2 innate lymphoid cells
Source: International Congress 2018 – Roles of innate lymphoid cells in asthma
Year: 2018
COX-1 driven biosynthesis of PGD2 during activation of human mast cells prevents formation of other prostanoids
Source: Virtual Congress 2020 – Novel molecular markers and targets for asthma phenotypes
Year: 2020
Effect of OVA activated tolerogenic mouse bone marrow dendritic cells on the production of IL-17 in vitro
Source: Annual Congress 2013 –Murine models of lung immunology
Year: 2013
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept